Egypt’s Minister of Health and Population, Khaled Abdel-Ghaffar, underscored the importance of strengthening partnerships with leading international healthcare companies to improve the quality and efficiency of renal care services, promote technology transfer and advance the localisation of medical supplies manufacturing in Egypt.
The minister made these remarks during a meeting with the Executive Vice President and Head of International Commercial Operations at Fresenius Medical Care, Thomas Swinnen, and his accompanying delegation, on the sidelines of the World Health Summit in Berlin.
The meeting explored avenues for co-operation in the healthcare sector, with particular emphasis on developing renal care and dialysis services.
Health Ministry Spokesman Hossam Abdel-Ghaffar stated that discussions focused on enhancing collaboration in renal care through the adoption of digital solutions and innovative technologies, the development of specialised training programmes, and the implementation of sustainable practices to improve service delivery and patient outcomes.
The meeting also addressed opportunities to localise the manufacturing of dialysis supplies and technologies in Egypt, alongside transferring advanced medical technologies and expertise.
These efforts aim to strengthen domestic manufacturing capabilities, reduce reliance on external supply chains and ensure the sustainable availability of essential medical supplies.
Both sides further explored prospects for positioning Egypt as a regional hub for renal care services serving African countries.
The proposed co-operation would encompass specialised training, technical support and the provision of integrated care solutions, facilitating knowledge exchange and contributing to the development of healthcare capacities across the continent.
Discussions also highlighted the importance of expanding co-operation in the prevention of chronic kidney disease and developing comprehensive, integrated care pathways.
These efforts seek to strengthen early detection, slow disease progression, reduce complications and mitigate the long-term health and financial burdens on patients and the healthcare system.
